Industries > Pharma > Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031

Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031

In-depth Analysis of Top 50 Ophthalmic Drug Manufacturers: Capabilities, Results, Competition and Sales Potentials

PUBLISHED: 04 March 2021
PAGES: 397
PRODUCT CODE: PHA1077
SUBMARKET: Therapeutic Drugs

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1077 Categories: , Tags: , , , , ,

Visiongain has published a new Pharma Leader Series report on Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031. The global ophthalmic drugs manufacturers market is estimated to be valued at US$xx billion in 2021 and is projected to reach at a market value of US$xx billion by 2031.

Curious to know how hard the COVID-19 has Impacted the Competitor’s Revenue?
Buy this report to discover the impact of COVID-19 and the subsequent recession/ economic recovery on the ophthalmic drugs manufacturers. Establish which of the new mergers, acquisitions and collaborations are changing competitive dynamics today.

Are you in the global race? Where do you stand in the cut throat global competition?
The global market for ophthalmic drugs is increasing yearly. Your competitors in the ophthalmic drugs market are benefiting from key opportunities – what are they and how can you benefit? This report will tell you.

With product approvals over the next decade set to be a key issue facing all competitors in the market – you must discover the essential strategies being implemented by key market players between 2015 and Jan 2021.

To access the data contained in this document please email contactus@visiongain.com

Buy this report to find out analysis of strategies adopted by Top 50 players in the market to stay ahead for their competitor.

Successful harnessing of the opportunities for growth in the ophthalmic pharmaceuticals market will depend upon the development of novel products with technologies that increase clinical effectiveness and development of products for previously-untreated ophthalmic conditions. Products based on superior technology, particularly those technologies that increase clinical effectiveness or increase patient compliance, are more likely to succeed.

How this report will benefit you?
The 397-page report provides clear detailed insight into the ophthalmic drugs manufacturers market. Discover the global top 50 rankings, top business strategies adopted by the key players, product mapping, services provided, recent activities of the companies, key drivers and challenges affecting the market.

Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 397-page report you will receive 300+ tables and 200+ figures– all unavailable elsewhere.

By ordering and reading our brand-new report today you stay better informed and ready to act. Visiongain’s study is intended for anyone requiring commercial analyses for the top 50 ophthalmic drugs manufacturers market. You find data, trends and predictions.

Top 50 Companies Profiled in the Report

Top 20 Big Ophthalmic Drugs Manufacturing Company Profiles
• Johnson & Johnson Vision Company
• Roche Holding AG (Roche)
• Pfizer
• Novartis AG
• Merck & Co.
• AbbVie Inc
• Takeda
• Essilor International S.A.
• Teva Pharmaceuticals
• Otsuka Pharmaceutical
• Bausch Health
• Alcon Inc.
• Regeneron Pharmaceuticals Inc.
• Edwards Lifesciences Corp
• Coopervision Company
• Santen Pharmaceuticals
• Rohto Pharmaceutical Co., Ltd.
• Carl Zeiss Meditec AG

Top 20 Mid-Range Ophthalmic Drugs Manufacturing Company Profiles
• Topcon Corporation
• Veeva System Inc
• Recipharm AB
• Menicon co ltd.
• Chengdu Kanghong Pharmaceutical
• Beximco
• Glaukos Corporation
• Staar Surgicals
• Omeros
• Aerie Pharmaceuticals
• Hoya Corporation
• Alimera Sciences
• Bora Pharmaceuticals Co Ltd
• Iridex
• EyeGate Pharmaceuticals
• Kalvista Pharmaceuticals Inc
• Ellex Medical Lasers Ltd.
• Thrombo Genics NV
• EyeGate Pharmaceuticals
• OphthaliX /Wize Pharma

Top 10 Ophthalmic Drugs Manufacturing Companies to Watch
• Gensight Biologics
• Neurotech
• Phio Pharmaceuticals Corp
• Kubota Pharmaceutical Holdings Co Ltd
• Aerpio Therapeutics
• Ampio Pharmaceuticals
• Kodiak Sciences Inc
• Opsis Therapeutics
• Grevis Pharmaceutical
• The Innovexia Life Sciences

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031: In-depth Analysis of Top 50 Ophthalmic Drug Manufacturers: Capabilities, Results, Competition and Sales Potentials. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031

    Download sample pages

    Complete the form below to download your free sample pages for Pharma Leader Series: Top 50 Ophthalmic Drug Manufacturers Market Report 2021-2031

      Latest Pharma news

      Visiongain Publishes Antibiotics Market Report 2023-2033

      The antibiotics market was valued at US$44,567.3 million in 2022 and is projected to grow at a CAGR of 4.15% during the forecast period 2023-2033.

      31 January 2023

      READ

      Visiongain Publishes Clinical Trial Supplies Market Report 2023-2033

      The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.

      31 January 2023

      READ

      Visiongain Publishes Meningococcal Vaccines Market Report 2023-2033

      The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.

      31 January 2023

      READ

      Visiongain Publishes Human Microbiome Market Report 2023-2033

      The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.

      30 January 2023

      READ